3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Obesity
1
Myelodysplastic Syndromes
1
Malnutrition
1
Gastrointestinal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Merkel Cell
1
Interventions
Cyclophosphamide
15
Antilymphocyte Serum
11
fludarabine phosphate
10
Cyclosporine
9
Busulfan
9
Peripheral Blood Stem Cell Transplantation
8
Mycophenolic Acid
7
Filgrastim
7
Methotrexate
6
Whole-Body Irradiation
5
Melphalan
5
fludarabine
4
Radiotherapy
4
Methylprednisolone
4
Cord Blood Stem Cell Transplantation
4
Tacrolimus
3
Psychiatric Rehabilitation
3
Palliative Care
3
Blood Specimen Collection
3
sargramostim
2
Thiotepa
2
Therapeutics
2
Stem Cell Transplantation
2
Polymerase Chain Reaction
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Behavior Therapy
2
Ascorbic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Myelodysplastic Syndromes
×
Sampling Studies
×
Clear all
NCT02809222
2021-04-19
PLASMYC
University Hospital, Tours
Phase NA
Completed
138 enrolled